← All companies

ALVO

Alvotech

ALVO Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$3.79

+0.22 +6.16%

Key statistics

from XBRL data in SEC filings

Market cap

$1.18B

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$2.94 – $9.25

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K Jul 29, 2026 6-K FORM 6-K Jul 1, 2026 6-K FORM 6-K Jun 18, 2026 6-K Jun 17, 2026 6-K Jun 15, 2026 6-K FORM 6-K Jun 8, 2026 6-K FORM 6-K Jun 4, 2026 6-K FORM 6-K May 11, 2026 6-K FORM 6-K May 4, 2026 20-F Mar 31, 2026 6-K FORM 6-K Mar 19, 2026 6-K FORM 6-K Feb 27, 2026 6-K FORM 6-K Feb 5, 2026 6-K FORM 6-K Feb 2, 2026 6-K FORM 6-K Jan 29, 2026 6-K FORM 6-K Jan 7, 2026 6-K FORM 6-K Jan 7, 2026 6-K FORM 6-K Jan 6, 2026 6-K FORM 6-K Jan 2, 2026 6-K FORM 6-K Dec 23, 2025 6-K FORM 6-K Dec 19, 2025 6-K FORM 6-K Dec 17, 2025 6-K FORM 6-K Nov 24, 2025 6-K FORM 6-K Nov 20, 2025 6-K FORM 6-K Nov 17, 2025 6-K FORM 6-K Nov 12, 2025 6-K FORM 6-K Nov 6, 2025 6-K FORM 6-K Nov 3, 2025 6-K FORM 6-K Oct 22, 2025 6-K FORM 6-K Oct 6, 2025 6-K FORM 6-K Sep 22, 2025 6-K Aug 13, 2025 6-K Jul 28, 2025 6-K FORM 6-K Jul 10, 2025 6-K FORM 6-K Jul 9, 2025 6-K FORM 6-K Jul 1, 2025 6-K FORM 6-K Jun 25, 2025 6-K FORM 6-K Jun 23, 2025 6-K FORM 6-K Jun 12, 2025 6-K FORM 6-K Jun 11, 2025